Daiwa Securities Group’s Medicines Co MDCO Stock Holding History

Daiwa Securities Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-506	Closed	-$43K	–	1253
2019 Q4	$43K	Hold	506	–	–	﹤0.01%	971
2019 Q3	$25K	Buy	506 +36	+8%	+$1.44K	﹤0.01%	985
2019 Q2	$17K	Hold	470	–	–	﹤0.01%	1024
2019 Q1	$13K	Sell	470 -19,933	-98%	-$470K	﹤0.01%	1021
2018 Q4	$390K	Buy	20,403 +20,000	+4,963%	+$465K	﹤0.01%	666
2018 Q3	$12K	Hold	403	–	–	﹤0.01%	1026
2018 Q2	$15K	Hold	403	–	–	﹤0.01%	1026
2018 Q1	$13K	Buy	+403	New	+$12.6K	﹤0.01%	1014

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Daiwa Securities Group's MDCO Position: Q1 2020 in Review

Daiwa Securities Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 506 shares — an estimated $43K sold.

Daiwa Securities Group first reported a position in MDCO in Q1 2018 and held it in 8 quarters. The position peaked at $390K in Q4 2018. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Daiwa Securities Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Daiwa Securities Group sold 506 Medicines Co shares in Q1 2020, an estimated $43K.
Daiwa Securities Group first reported a position in Medicines Co in Q1 2018 and held it in 8 quarters.
Daiwa Securities Group's Medicines Co position peaked at $390K in Q4 2018.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.